Hygeia Healthcare Holdings Co Ltd (6078:HK) Stock Forecast
Alert
Its only available to paid users.
N/A
Based on the Hygeia Healthcare Holdings Co Ltd stock forecast from 0 analysts, the average analyst target price for Hygeia Healthcare Holdings Co Ltd is not available over the next 12 months. Hygeia Healthcare Holdings Co Ltd’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Hygeia Healthcare Holdings Co Ltd is Slightly Bullish , which is based on 7 positive signals and 5 negative signals. At the last closing, Hygeia Healthcare Holdings Co Ltd’s stock price was HKD 32.40. Hygeia Healthcare Holdings Co Ltd’s stock price has changed by +14.49% over the past week, +6.23% over the past month and -43.65% over the last year.
No recent analyst target price found for Hygeia Healthcare Holdings Co Ltd
No recent average analyst rating found for Hygeia Healthcare Holdings Co Ltd
Company Overview Hygeia Healthcare Holdings Co Ltd
Hygeia Healthcare Holdings Co., Limited operates as an oncology healthcare company in the People's Republic of China. The company owns and operates private for-profit hospitals that offers oncology healthcare services, such as radiotherapy, chemotherapy, surgery, and targeted therapy, as well as cancer diagnosis, treatment, and rehabilitation. It also provides radiotherapy center consulting services; and licenses its SRT equipment, as well as offers maintenance and technical support services for its SRT equipment. In addition, the company provides hospital and corporate management, and supply chain services. It operates or manages a network of oncology-focused hospitals. The company was founded in 2009 and is headquartered in Shanghai, the People's Republic of China. Read Less
Hygeia Healthcare Holdings Co., Limited operates as an oncology healthcare company in the People's Republic of China. The company owns and operates private for-profit hospitals that offers oncology healthcare services, such as radiotherapy, chemotherapy, surgery, and targeted the...Read More
Frequently Asked Questions About Hygeia Healthcare Holdings Co Ltd (6078:HK) Stock
Stock Target Advisor's fundamental analysis for Hygeia Healthcare Holdings Co Ltd's stock is Slightly Bullish .
6078:HK stock's dividend yield is 0.58%.
Our analysis grades 6078:HK stock's dividend yield at F. This means that 6078:HK stock's dividend yield is above 14% of the stocks in the Medical Care Facilities sector in the HK exchange.
Based on this 6078:HK may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on 6078:HK's stock to indicate what its average analyst target is.
6078:HK stock's Price/Earning ratio is 24.23.
Our analysis grades 6078:HK stock's Price / Earning ratio at F. This means that 6078:HK stock's Price/Earning ratio is above 41% of the stocks in the Medical Care Facilities sector in the HK exchange.
Based on this 6078:HK may be fairly valued for its sector
The last closing price of 6078:HK's stock was HKD 32.40.
The most recent market capitalization for 6078:HK is HKD 17.90B.
Unfortunately we do not have enough analyst data on 6078:HK's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Hygeia Healthcare Holdings Co Ltd's stock.
As per our most recent records Hygeia Healthcare Holdings Co Ltd has 8,238 Employees.
Hygeia Healthcare Holdings Co Ltd's registered address is Enterprise Square, Shanghai, China.
You can get more information about it from Hygeia Healthcare Holdings Co Ltd's website at https://www.hygeia-group.com.cn.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 6078:HK !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
